JP2024529369A5 - - Google Patents

Info

Publication number
JP2024529369A5
JP2024529369A5 JP2024502616A JP2024502616A JP2024529369A5 JP 2024529369 A5 JP2024529369 A5 JP 2024529369A5 JP 2024502616 A JP2024502616 A JP 2024502616A JP 2024502616 A JP2024502616 A JP 2024502616A JP 2024529369 A5 JP2024529369 A5 JP 2024529369A5
Authority
JP
Japan
Application number
JP2024502616A
Other languages
Japanese (ja)
Other versions
JPWO2023009622A5 (https=
JP2024529369A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038520 external-priority patent/WO2023009622A1/en
Publication of JP2024529369A publication Critical patent/JP2024529369A/ja
Publication of JP2024529369A5 publication Critical patent/JP2024529369A5/ja
Publication of JPWO2023009622A5 publication Critical patent/JPWO2023009622A5/ja
Pending legal-status Critical Current

Links

JP2024502616A 2021-07-28 2022-07-27 Aavトランスファープラスミド Pending JP2024529369A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226410P 2021-07-28 2021-07-28
US63/226,410 2021-07-28
PCT/US2022/038520 WO2023009622A1 (en) 2021-07-28 2022-07-27 Aav transfer plasmids

Publications (3)

Publication Number Publication Date
JP2024529369A JP2024529369A (ja) 2024-08-06
JP2024529369A5 true JP2024529369A5 (https=) 2025-07-08
JPWO2023009622A5 JPWO2023009622A5 (https=) 2025-07-08

Family

ID=85087966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502616A Pending JP2024529369A (ja) 2021-07-28 2022-07-27 Aavトランスファープラスミド

Country Status (8)

Country Link
US (1) US20250099617A1 (https=)
EP (1) EP4377471A4 (https=)
JP (1) JP2024529369A (https=)
CN (1) CN118043474A (https=)
AU (1) AU2022319723A1 (https=)
CA (1) CA3225271A1 (https=)
IL (1) IL310145A (https=)
WO (1) WO2023009622A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025176847A1 (en) * 2024-02-21 2025-08-28 Ags Therapeutics Sas Ocular delivery of active agents via microalgae extracellular vesicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868149B2 (en) * 1999-07-20 2011-01-11 Monsanto Technology Llc Plant genome sequence and uses thereof
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
US10059983B2 (en) * 2012-09-10 2018-08-28 Genesky Diagnostics (Suzhou) Inc. Multiplex nucleic acid analysis
MX384795B (es) * 2013-03-15 2025-03-14 Childrens Hospital Philadelphia Vectores que comprenden secuencias de polinucleotidos rellenadoras/de relleno y metodos de uso.
WO2017161273A1 (en) * 2016-03-18 2017-09-21 The Children's Hospital Of Philadelphia Therapeutic for treatment of diseases including the central nervous system
US10240205B2 (en) * 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
EP3870148A4 (en) * 2018-10-25 2022-11-09 Takeda Pharmaceutical Company Limited AAV TRIPLE PLASMID SYSTEM
CA3136117A1 (en) * 2019-04-10 2020-10-15 Prevail Therapeutics, Inc. Gene therapies for lysosomal disorders

Similar Documents

Publication Publication Date Title
CL2025004118A1 (es) Composiciones y métodos de inhibición de la adenilato ciclasa 9 (ac9).
JP2024529369A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307048472S (https=)
BY13176U (https=)
CN307046336S (https=)
CN307045445S (https=)
CN307044817S (https=)
CN307044383S (https=)
CN307046760S (https=)
BY23965C1 (https=)
BY23963C1 (https=)
BY13175U (https=)
BY13174U (https=)